Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Go to Main Navigation

Maria Thompson

Maria Thompson, PhD has a background in molecular genetics and over 16 years of experience in pharmaceutical and diagnostics research and development. She has held a variety of roles including Head of Genome Wide Screening for Type 2 diabetes, Six Sigma Black Belt, and VP of Scientific Affairs. Dr. Thompson is a Principal Consultant at APEX Think, a private consulting company providing scientific and technical advisory services to clients across the life science industry. Dr. Thompson holds a BSc in Genetics and a PhD in Molecular and Cellular Biochemistry from the Royal London School of Medicine, UK.
Showing 21-30 of 110 posts
Oct 3, 2013

Modern medicine has made incredible advances with treatments that have changed the prospects for many diseases. The healthcare and pharmaceutical...

Oct 1, 2013

This is Part 2 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 3). A personalized medicine approach to clinical...

Sep 26, 2013

This is Part 1 in a three-part series on patient-centered outcomes. (Check out Part 2 and Part 3). In different regulatory and research settings...

Sep 24, 2013

Looking back on papers published in high profile journals over the years, the path to publication has become ever more involved. The number of...

Sep 19, 2013

Each week Brian Britt, veteran Union Tribune radio host, interviews the San Diego’s best and brightest, thought leaders and visionaries for his...

Sep 16, 2013

Core labs at academic institutes lower the barrier to expensive technology and give people access to techniques outside their field of expertise...

Sep 12, 2013

Over the past few weeks we have covered a series of blogs from Steve Blank, the Silicon Valley serial-entrepreneur and academician who is...

Sep 10, 2013

Targeted based drug discovery has been a mainstay of pharmaceutical pipelines for the last 20 years. Identifying and validating novel drug...

Sep 5, 2013

Its been a wonderfully busy few months for Scientist and awards! In July, we were given a CIO award, a Pharmavoice 100 award. In August, we were...

Sep 3, 2013

Steve Blank wrote an excellent 3 part blog series last week. We covered Part 1 which described the challenges Life Science companies face in...